Enoxaparin Sodium For Injection Market

Enoxaparin Sodium For Injection Market contains market size and forecasts of Enoxaparin Sodium For Injection in global, including the following market information:
Global Enoxaparin Sodium For Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Enoxaparin Sodium For Injection Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Enoxaparin Sodium For Injection companies in 2021 (%)
The global Enoxaparin Sodium For Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
40mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Enoxaparin Sodium For Injection include Sanofi, Teva Pharmaceutical, Techdow (Hepalink), Fresenius Kabi, Amphastar Pharmaceuticals, Hangzhou Jiuyuan Gene Engineering, Suzhou Erye Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical and Chengdu Baiyu Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Enoxaparin Sodium For Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Enoxaparin Sodium For Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Enoxaparin Sodium For Injection Market Segment Percentages, by Type, 2021 (%)
40mg
100mg
Other
Global Enoxaparin Sodium For Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Enoxaparin Sodium For Injection Market Segment Percentages, by Application, 2021 (%)
Prevents Intravenous Thrombosis
Deep Vein Embolism Treatment
Other
Global Enoxaparin Sodium For Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Enoxaparin Sodium For Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Enoxaparin Sodium For Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Enoxaparin Sodium For Injection revenues share in global market, 2021 (%)
Key companies Enoxaparin Sodium For Injection sales in global market, 2017-2022 (Estimated), (Units)
Key companies Enoxaparin Sodium For Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Teva Pharmaceutical
Techdow (Hepalink)
Fresenius Kabi
Amphastar Pharmaceuticals
Hangzhou Jiuyuan Gene Engineering
Suzhou Erye Pharmaceutical
Nanjing King-friend Biochemical Pharmaceutical
Chengdu Baiyu Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical

Beijing SL Pharmaceutical
Troikaa Pharmaceuticals